Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lizonova

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Vascular Surgery|February 9, 2000
Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cellsM R Kibbe, S Nie, D W Seol, et al.
Journal of Virology|October 1, 1996
Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodiesT J Wickham, D M Segal, P W Roelvink, et al.
Developments in Biologicals|March 29, 2006
Comprehensive characterization of the 293-ORF6 cell lineB T Butman, A Lizonova, D E Brough, et al.
The Journal of Clinical Investigation|October 23, 1997
Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosisL L Shears, N Kawaharada, E Tzeng, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 11, 2000
Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectorsM R Kibbe, A Murdock, T Wickham, et al.
Journal of the American College of Surgeons|September 18, 1998
Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivoL L Shears, M R Kibbe, A D Murdock, et al.
Human Gene Therapy|January 26, 2000
Improved production of adenovirus vectors expressing apoptotic transgenesJ T Bruder, A Appiah, W M Kirkman, et al.
Journal of Vascular Surgery|June 8, 2000
Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphateM R Kibbe, J Li, S Nie, et al.
Journal of Virology|October 29, 1997
Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteinsT J Wickham, E Tzeng, L L Shears, et al.
Journal of Virology|September 12, 1998
The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and FP W Roelvink, A Lizonova, J G Lee, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Vascular Surgery|February 9, 2000
Nitric oxide prevents p21 degradation with the ubiquitin-proteasome pathway in vascular smooth muscle cellsM R Kibbe, S Nie, D W Seol, et al.
Journal of Virology|October 1, 1996
Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodiesT J Wickham, D M Segal, P W Roelvink, et al.
Developments in Biologicals|March 29, 2006
Comprehensive characterization of the 293-ORF6 cell lineB T Butman, A Lizonova, D E Brough, et al.
The Journal of Clinical Investigation|October 23, 1997
Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosisL L Shears, N Kawaharada, E Tzeng, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 11, 2000
Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectorsM R Kibbe, A Murdock, T Wickham, et al.
Journal of the American College of Surgeons|September 18, 1998
Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivoL L Shears, M R Kibbe, A D Murdock, et al.
Human Gene Therapy|January 26, 2000
Improved production of adenovirus vectors expressing apoptotic transgenesJ T Bruder, A Appiah, W M Kirkman, et al.
Journal of Vascular Surgery|June 8, 2000
Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphateM R Kibbe, J Li, S Nie, et al.
Journal of Virology|October 29, 1997
Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteinsT J Wickham, E Tzeng, L L Shears, et al.
Journal of Virology|September 12, 1998
The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and FP W Roelvink, A Lizonova, J G Lee, et al.
Pageof 3